Genetic Technologies Ltd.
GENE
GENE was delisted on the 16th of October, 2024.
6 hedge funds and large institutions have $103K invested in Genetic Technologies Ltd. in 2023 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 6 closing their positions.
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
21% less capital invested
Capital invested by funds: $130K → $103K (-$26.7K)
45% less funds holding
Funds holding: 11 → 6 (-5)
83% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 6
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TSS
Two Sigma Securities
New York
|
+$767 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VF
Virtu Financial
New York
|
-$15K |
| 2 |
GI
Gradient Investments
Arden Hills,
Minnesota
|
-$1.82K |
| 3 |
Wells Fargo
San Francisco,
California
|
-$831 |
| 4 |
Morgan Stanley
New York
|
-$571 |
| 5 |
Simplex Trading
Chicago,
Illinois
|
-$534 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Morgan Stanley
New York
| $66.8K | -$571 | -140 | -0.8% |
|
2
RhumbLine Advisers
Boston,
Massachusetts
| $14.4K | – | – | – |
|
|
TSS
3
Two Sigma Securities
New York
| $12.1K | +$767 | +188 | +6% |
|
|
SA
4
Scarborough Advisors
Annapolis,
Maryland
| $8.11K | – | – | – |
|
|
FDCDDQ
5
Federation des caisses Desjardins du Quebec
Levis,
Quebec, Canada
| $1.53K | – | – | – |
|
|
PWA
6
Provenance Wealth Advisors
Fort Lauderdale,
Florida
| $57 | +$61 | +15 | New |
|
|
VF
7
Virtu Financial
New York
| – | -$15K | -3,636 | Closed |
|
|
GI
8
Gradient Investments
Arden Hills,
Minnesota
| – | -$1.82K | -438 | Closed |
|
|
9
Wells Fargo
San Francisco,
California
| – | -$831 | -200 | Closed |
|
|
10
Simplex Trading
Chicago,
Illinois
| – | -$534 | -131 | Closed |
|
|
NC
11
NewSquare Capital
Newtown Square,
Pennsylvania
| – | -$83 | -20 | Closed |
|
12
UBS Group
Zurich,
Switzerland
| – | -$83 | -20 | Closed |
|
GENE Hedge Fund Activity: Q3 2023 in Review
6 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in Genetic Technologies Ltd. (GENE) for Q3 2023, worth a combined $103K — down 21% from $130K a quarter earlier.
Sellers outnumbered buyers: 6 funds closed out of GENE and 1 opened new positions — a net loss of 5 holders — while 1 trimmed existing stakes and 1 added.
The largest buyer was Two Sigma Securities, adding an estimated $767. The largest seller was Virtu Financial, exiting entirely with an estimated $15K sold.
- 6 institutional investors held Genetic Technologies Ltd. (GENE) as of Q3 2023, down from 11 in Q2 2023.
- Funds reported $103K of Genetic Technologies Ltd. stock for Q3 2023, down 21% quarter-over-quarter.
- 1 fund opened new Genetic Technologies Ltd. positions in Q3 2023 and 6 closed out, a net change of -5 holders.
- The largest Genetic Technologies Ltd. buyer in Q3 2023 was Two Sigma Securities, an estimated $767 added.
- The largest Genetic Technologies Ltd. seller in Q3 2023 was Virtu Financial, an estimated $15K sold.
Based on aggregated 13F filings for Q3 2023.